vigabatrin has been researched along with HIV Infections in 1 studies
HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
| Excerpt | Relevance | Reference |
|---|---|---|
| " For vigabatrin, demonstration of similar dose-response between pediatrics and adults allowed for selection of a pediatric dose." | 2.53 | Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling. ( Bhattaram, A; Earp, JC; Florian, J; Krudys, K; Lee, JE; Lee, JY; Liu, J; Mehrotra, N; Mulugeta, Y; Sinha, V; Yu, J; Zhao, P, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehrotra, N | 1 |
| Bhattaram, A | 1 |
| Earp, JC | 1 |
| Florian, J | 1 |
| Krudys, K | 1 |
| Lee, JE | 1 |
| Lee, JY | 1 |
| Liu, J | 1 |
| Mulugeta, Y | 1 |
| Yu, J | 1 |
| Zhao, P | 1 |
| Sinha, V | 1 |
1 review available for vigabatrin and HIV Infections
| Article | Year |
|---|---|
Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.
Topics: Adalimumab; Adolescent; Adolescent Development; Adult; Age Factors; Anti-HIV Agents; Anti-Inflammato | 2016 |